Ladenburg Thalmann & Co. Inc. - Medical Equipment - Advisory Profile

Date: February 28, 2014
Pages: 79
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: LC503533BC4EN
Leaflet:

Download PDF Leaflet

Ladenburg Thalmann & Co. Inc. - Medical Equipment - Advisory Profile
Summary

Ladenburg Thalmann & Co. Inc. (LTCI) is an investment banking and brokerage firm. It holds expertise in providing capital markets, financial advisory and value-added services. The firm offers servicesrelated to equity research, institutional sales and trading, investment banking and private client services. It caters services to health care, power and utilities, energy and financial sectors. The firm has its operational presence with offices located in Miami, Boca Raton, New York, Melville, Princeton, Boston, Houston, Naples and Calabasas in the US. It is a subsidiary of Ladenburg Thalmann Financial Services Inc (LTFS), which is a full service financial company. LTCI is headquartered in New York, the US.

GlobalData’s Ladenburg Thalmann & Co. Inc. - Medical Equipment - Advisory Profile provides an overview of the deals advised by Ladenburg Thalmann & Co. Inc. in the Medical Devices market. The report is an essential source of information for Medical Devices companies, which require the services of financial/legal advisors in their area/region for raising capital or acquiring a company. The report summarizes Ladenburg Thalmann & Co. Inc.'s deals for the past five years segregated into year, deal type, segment and geography.

Scope
  • Provides essential information on the financial deals in which the firm provided financial/legal advisory services. The deals include mergers and acquisitions, asset financing, asset transactions, private equity / venture capital deals, equity offerings, debt offerings, partnerships, and licensing agreements
  • Outlines key advisor information for business intelligence needs such as name, business overview, location and contact information
  • Analyzes the advisor’s deals by year, deal type, segment and geography
  • Provides detailed information on deal particulars, including information about other advisors involved in the deal
  • Includes information on the role played by the advisor in specific deals, and the extent of fees/commission charged by the advisor in a particular transaction, if disclosed
  • Consists of Deals Advised by Year chart and table displaying information on the number of deals and value reported by the advisor by year, for a five year period
  • Incorporates information on the major recent financial deals of the advisor. Each such deal carries a summary, deal type, deal rationale, deal financials and target company’s key financial metrics and ratios (financials are available for major public companies).
Reasons to Buy
  • Receive detailed information and evaluate the profile of a particular advisor in the market before considering for your business needs
  • Peruse all the advisor’s deals in the Industry market
  • Access detailed information about the advisor’s financial deals for the past five years that enable you to scrutinize the key deals, which have shaped investment policies
  • Identify other potential advisors currently active in your industry, or industry that you wish to foray into
  • Compare your advisory services vis-à-vis your competitors’
  • Check and identify the advisor that suits your requirements, such as placement agents, book-runners and underwriters
  • Examine the breakdown of deals by category and detailed information on major deals incorporated in the advisor’s profile for your academic or business research needs and their suitability to your requirements.
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised By Year, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised By Type, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised By Region, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised By Market, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised Summary, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment, Deal Details
Debt Offerings
Jabil Circuit Completes Public Offering Of 7.75% Senior Notes For US$312 Million
Genetic Technologies Completes Private Placement Of Notes For US$5 Million
Liberator Medical Supply Completes Private Placement Of US$2.5 Million
Equity Offerings
Response Genetics Completes Private Placement Of Shares For US$2 Million
CareView Communications Completes Private Placement Of Shares For US$3.1 Million
Pressure BioSciences Completes Private Placement Of Units For US$0.41 Million
OPKO Health Completes Exercise Of Underwriters’ Over-allotment Option For US$110 Million
CombiMatrix Completes Public Offering Of Units For US$12 Million
Oxygen Biotherapeutics Completes Private Placement Of Shares For US$2 Million
AspenBio Pharma Completes Private Placement Of Common Stock For US$1.6 Million
pSivida Completes Registered Direct Offering Of Units For US$11 Million
Mazor Robotics Completes Public Offering Of American Depositary Shares For US$47 Million
Cardium Therapeutics Completes Second Tranche Of Private Placement Of Preferred Stock For US$1.7 Million
Cardium Therapeutics Completes Private Placement Of Common Stock For US$5 Million
Bioanalytical Systems Completes Registered Public Offering Of US$5.5 Million
Aradigm Completes Private Placement Of US$4.46 Million
Dara BioSciences Announces Private Placement Of Shares For US$6 Million
Navidea Biopharma Completes Public Offering Of Common Stock For US$5 Million
Pressure BioSciences Completes Private Placement Of Series E Convertible Preference Stock For US$0.5 Million
Aradigm Completes Private Placement Of Shares For US$4.75 Million
Antares Pharma Completes Private Placement Of Units For US$8.5 Million
NeoGenomics Completes Public Offering Of Shares For US$10 Million
Pressure BioSciences Files Preliminary Registration Statement For Public Offering Of Units For US$8 Million
Aradigm Completes Private Placement Of US$4 Million
pSivida Completes Public Offering Of Shares For US$10.8 Million
Navidea Biopharma Completes Private Placement Of Shares For US$5 Million
Pressure BioSciences Completes Registered Direct Offering Of Units For US$0.84 Million
PhotoMedex Completes Public Offering Of Common Stock For US$3.2 Million
AxoGen Completes Underwriters’ Exercise Of Partial Over-Alotment Option Of Public Offering Of Shares For US$18.6 Million
Cleveland BioLabs Completes Public Offering Of Units For US$17 Million
NeurogesX Completes Private Placement Of Units For US$20 Million
Oxygen Biotherapeutics Completes Public Offering Of Units For US$5.4 Million
BioDelivery Sciences Completes Public Offering Of Common Stock And Prferred Stock For US$40 Million
Lucid Completes IPO Of Units For US$6 Million
NeuroMetrix Completes Private Placement Of Units For US$19 Million
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Ladenburg Thalmann & Co. Inc., Key Facts
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised Summary, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised By Year, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised By Type, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised By Region, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc. Deals Advised By Market, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised Summary, 2008 to YTD 2014
Jabil Circuit Completes Public Offering Of 7.75% Senior Notes For US$312 Million
Genetic Technologies Completes Private Placement Of Notes For US$5 Million
Liberator Medical Supply Completes Private Placement Of US$2.5 Million
Response Genetics Completes Private Placement Of Shares For US$2 Million
CareView Communications Completes Private Placement Of Shares For US$3.1 Million
Pressure BioSciences Completes Private Placement Of Units For US$0.41 Million
OPKO Health Completes Exercise Of Underwriters’ Over-allotment Option For US$110 Million
CombiMatrix Completes Public Offering Of Units For US$12 Million
Oxygen Biotherapeutics Completes Private Placement Of Shares For US$2 Million
AspenBio Pharma Completes Private Placement Of Common Stock For US$1.6 Million
pSivida Completes Registered Direct Offering Of Units For US$11 Million
Mazor Robotics Completes Public Offering Of American Depositary Shares For US$47 Million
Cardium Therapeutics Completes Second Tranche Of Private Placement Of Preferred Stock For US$1.7 Million
Cardium Therapeutics Completes Private Placement Of Common Stock For US$5 Million
Bioanalytical Systems Completes Registered Public Offering Of US$5.5 Million
Aradigm Completes Private Placement Of US$4.46 Million
Dara BioSciences Announces Private Placement Of Shares For US$6 Million
Navidea Biopharma Completes Public Offering Of Common Stock For US$5 Million
Pressure BioSciences Completes Private Placement Of Series E Convertible Preference Stock For US$0.5 Million
Aradigm Completes Private Placement Of Shares For US$4.75 Million
Antares Pharma Completes Private Placement Of Units For US$8.5 Million
NeoGenomics Completes Public Offering Of Shares For US$10 Million
Pressure BioSciences Files Preliminary Registration Statement For Public Offering Of Units For US$8 Million
Aradigm Completes Private Placement Of US$4 Million
pSivida Completes Public Offering Of Shares For US$10.8 Million
Navidea Biopharma Completes Private Placement Of Shares For US$5 Million
Pressure BioSciences Completes Registered Direct Offering Of Units For US$0.84 Million
PhotoMedex Completes Public Offering Of Common Stock For US$3.2 Million
AxoGen Completes Underwriters’ Exercise Of Partial Over-Alotment Option Of Public Offering Of Shares For US$18.6 Million
Cleveland BioLabs Completes Public Offering Of Units For US$17 Million
NeurogesX Completes Private Placement Of Units For US$20 Million
Oxygen Biotherapeutics Completes Public Offering Of Units For US$5.4 Million
BioDelivery Sciences Completes Public Offering Of Common Stock And Prferred Stock For US$40 Million
Lucid Completes IPO Of Units For US$6 Million
NeuroMetrix Completes Private Placement Of Units For US$19 Million

LIST OF FIGURES

Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised by Deal Type, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised By Year, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised By Region, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised By Market, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised By Year, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised by Deal Type, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised By Region, 2008 to YTD 2014
Ladenburg Thalmann & Co. Inc., Medical Equipment Deals Advised by Market, 2008 to YTD 2014
Skip to top


Ask Your Question

Ladenburg Thalmann & Co. Inc. - Medical Equipment - Advisory Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: